DiaMedica Therapeutics Inc. (DMAC) Marketable Securities, Current USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
DiaMedica Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from 2019 to 2024.
  • DiaMedica Therapeutics Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $44.4 M, a 67.6% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $44.4 M +$17.9 M +67.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $48.4 M +$19.6 M +68% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $44.2 M +$10.9 M +32.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $34.5 M -$852 K -2.41% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $26.5 M -$11.5 M -30.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $28.8 M -$11.6 M -28.8% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $33.3 M +$1.44 M +4.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $35.4 M +$16.3 M +85.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $38 M +$17.9 M +89.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $40.4 M +$20.3 M +101% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $31.9 M +$11.1 M +53.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $19.1 M +$12.2 M +179% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $20.1 M +$10.7 M +115% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $20.1 M +$16.1 M +403% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $20.8 M +$15.8 M +316% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $6.84 M -$1.15 M -14.4% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $9.35 M -$1.61 M -14.7% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $4 M Dec 31, 2019 10-K 2021-03-10
Q3 2019 $5 M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $7.99 M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $11 M Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.